Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study

Authors

  • Laura Gnesotto Dermatology Unit, Department of Medicine, University of Padova, Via Cesare Battisti 206, IT-35128 Padua, Italy
  • Guido Mioso Dermatology Unit, Department of Medicine, University of Padova, Via Cesare Battisti 206, IT-35128 Padua, Italy
  • Federico Bardazzi Department of Experimental, Diagnostic and Specialty Medicine- Division of Dermatology, University of Bologna, Bologna, Italy
  • Federica Filippi Department of Experimental, Diagnostic and Specialty Medicine- Division of Dermatology, University of Bologna, Bologna, Italy
  • Vito Di Lernia Dermatology Unit, Arcispedale S. Maria Nuova, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
  • Alberico Motolese Dermatology Unit, Arcispedale S. Maria Nuova, Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy
  • Sergio Di Nuzzo Dermatology, Department of Medicine and Surgery, University of Parma, Parma, Italy
  • Andrea Conti Section of Dermatology, Department of Specialized Medicine, University of Modena and Reggio Emilia, Modena, Italy
  • Federica Arginelli Section of Dermatology, Department of Specialized Medicine, University of Modena and Reggio Emilia, Modena, Italy
  • Monica Corazza Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
  • Giulia Odorici Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
  • Alessandro Borghi Section of Dermatology and Infectious Diseases, Department of Medical Sciences, University of Ferrara, Ferrara, Italy
  • Paolo Gisondi Section of Dermatology, Department of Medicine, University of Verona, Verona, Italy
  • Luigi Naldi Dermatology Unit, San Bortolo Hospital, Vicenza, Italy
  • Paolo Dapavo Section of Dermatology, Department of Medical Sciences, University of Turin, Turin, Italy
  • Aurora Parodi University of Genova, DiSSal Section of Dermatology, San Martino Polyclinic Hospital IRCCS, Largo R. Benzi 10 16132 Genova, Italy
  • Martina Burlando University of Genova, DiSSal Section of Dermatology, San Martino Polyclinic Hospital IRCCS, Largo R. Benzi 10 16132 Genova, Italy
  • Stefano Piaserico Dermatology Unit, Department of Medicine, University of Padova, Padova, Italy

DOI:

https://doi.org/10.2340/actadv.v103.4526

Keywords:

Dimethyl fumarate, Elderly, Psoriasis, Therapy

Abstract

Abstract is missing (Short communication)

Downloads

Download data is not yet available.

References

Mrowietz U, Barker J, Boehncke WH, Iversen L, Kirby B, Naldi L, et al. Clinical use of dimethyl fumarate in moderate-to-severe plaque-type psoriasis: a European expert consensus. J Eur Acad Dermatol Venereol 2018; 32: 3-14.

https://doi.org/10.1111/jdv.15218 DOI: https://doi.org/10.1111/jdv.15218

Malara G, Fabbrocini G, Trifirò C, Burlando M. Dimethyl fumarate titration for the systemic treatment of moderate-to-severe plaque psoriasis. Drugs Context 2021; 10: 2020-12-4.

https://doi.org/10.7573/dic.2020-12-4 DOI: https://doi.org/10.7573/dic.2020-12-4

Lijnen R, Otters E, Balak D, Thio B. Long-term safety and effectiveness of high-dose dimethylfumarate in the treatment of moderate to severe psoriasis: a prospective single-blinded follow-up study. J Dermatolog Treat 2016; 27: 31-36.

https://doi.org/10.3109/09546634.2015.1050980 DOI: https://doi.org/10.3109/09546634.2015.1050980

Corazza M, Odorici G, Conti A, Di Lernia V, Motolese A, Bardazzi F, et al. Dimethyl fumarate treatment for psoriasis in a real-life setting: a multicentric retrospective study. Dermatol Ther 2021; 34: 15066.

https://doi.org/10.1111/dth.15066 DOI: https://doi.org/10.1111/dth.15066

Esposito M, Campanati A, Giunta A, Calianno G, Bianchi L, Diotallevi F, et al. Dimethyl fumarate's effectiveness and safety in psoriasis: a real-life experience during the COVID-19 pandemic. Dermatol Ther (Heidelb) 2022; 12: 671-681.

https://doi.org/10.1007/s13555-022-00684-3 DOI: https://doi.org/10.1007/s13555-022-00684-3

Pezzolo E, Cazzaniga S, Di Leo S, Naldi L; PsoReal Study Group. Efficacy and safety of dimethyl fumarate in comparison with conventional therapy for psoriasis: an Italian real-world clinical experience. J Eur Acad Dermatol Venereol. 2022; 36: 534-537

https://doi.org/10.1111/jdv.17997 DOI: https://doi.org/10.1111/jdv.17997

Hoefnagel JJ, Thio HB, Willemze R, Bouwes Bavinck JN. Long-term safety aspects of systemic therapy with fumaric acid esters in severe psoriasis. Br J Dermatol 2003; 149: 363-369.

https://doi.org/10.1046/j.1365-2133.2003.05433.x DOI: https://doi.org/10.1046/j.1365-2133.2003.05433.x

Walker F, Adamczyk A, Kellerer C, Belge K, Brück J, Berner T, et al. Fumaderm® in daily practice for psoriasis: dosing, efficacy and quality of life. Br J Dermatol 2014; 171: 1197-205.

https://doi.org/10.1111/bjd.13098 DOI: https://doi.org/10.1111/bjd.13098

Dickel H, Bruckner T, Altmeyer P. Long-term real-life safety profile and effectiveness of fumaric acid esters in psoriasis patients: a single-centre, retrospective, observational study. J Eur Acad Dermatol Venereol 2018; 32: 1710-1727.

https://doi.org/10.1111/jdv.15019 DOI: https://doi.org/10.1111/jdv.15019

Mrowietz U, Sorbe C, Reich K, Von Kiedrowski R, Weckbecker J, Radtke MA, et al. Fumaric acid esters for the treatment of psoriasis in Germany: characterising patients in routine care. Eur J Dermatol 2020; 30: 41-48.

Termeer C, Reinhold U, Dirschka T, von Kiedrowski R, Kurzen H. Long-term use of fumaric acid esters for the treatment of psoriasis in daily practice. J Dermatolog Treat 2021; 32: 610-616.

https://doi.org/10.1080/09546634.2019.1688234 DOI: https://doi.org/10.1080/09546634.2019.1688234

Ricceri F, Bardazzi F, Buggiani G, Burlando M, Campione E, Corazza M, et al. Efficacy and safety of dimethylfumarate in elderly psoriasis patients: a multicentric Italian study. J Dermatolog Treat 2021; 11: 1-4.

https://doi.org/10.1080/09546634.2021.1962000 DOI: https://doi.org/10.1080/09546634.2021.1962000

Mrowietz U, Szepietowski JC, Loewe R, van de Kerkhof P, Lamarca R, Ocker WG, et al. Efficacy and safety of LAS41008 (dimethyl fumarate) in adults with moderate-to-severe chronic plaque psoriasis: a randomized, double-blind, Fumaderm®-and placebo-controlled trial (BRIDGE). Br J Dermatol 2017; 176: 615-623.

https://doi.org/10.1111/bjd.14947 DOI: https://doi.org/10.1111/bjd.14947

Downloads

Additional Files

Published

2023-03-28

How to Cite

Gnesotto, L., Mioso, G., Bardazzi, F., Filippi, F., Di Lernia, V., Motolese, A. ., Di Nuzzo, S., Conti, A. ., Arginelli, F., Corazza, M., Odorici, G., Borghi, A., Gisondi, P., Naldi, L., Dapavo, P., Parodi, A. ., Burlando, M., & Piaserico, S. (2023). Dimethyl Fumarate Treatment in Patients with Moderate-to-Severe Psoriasis: A 52-week Real-life Study. Acta Dermato-Venereologica, 103, adv4526. https://doi.org/10.2340/actadv.v103.4526

Issue

Vol. 103 (2023)

Section

Short Communication

Categories

License

Copyright (c) 2023 Laura Gnesotto, Guido Mioso, Federico Bardazzi, Federica Filippi, Vito Di Lernia, Alberico Motolese, Sergio Di Nuzzo, Andrea Conti, Federica Arginelli, Monica Corazza, Giulia Odorici, Alessandro Borghi, Paolo Gisondi, Luigi Naldi, Paolo Dapavo, Aurora Parodi, Martina Burlando, Stefano Piaserico

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All digitalized ActaDV contents is available freely online. The Society for Publication of Acta Dermato-Venereologica owns the copyright for all material published until volume 88 (2008) and as from volume 89 (2009) the journal has been published fully Open Access, meaning the authors retain copyright to their work.

Unless otherwise specified, all Open Access articles are published under CC-BY-NC licences, allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material for non-commercial purposes, provided proper attribution to the original work.

Crossref
Scopus
Google Scholar
Europe PMC